These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24048097)

  • 1. The role of the opioid system in alcohol dependence.
    Nutt DJ
    J Psychopharmacol; 2014 Jan; 28(1):8-22. PubMed ID: 24048097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous opioid systems and alcohol addiction.
    Herz A
    Psychopharmacology (Berl); 1997 Jan; 129(2):99-111. PubMed ID: 9040115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid receptor antagonists in the treatment of pathological gambling.
    Coppola M; Mondola R
    J Opioid Manag; 2017; 13(4):205-206. PubMed ID: 28983886
    [No Abstract]   [Full Text] [Related]  

  • 4. Interactions between cannabinoid and opioid receptor systems in the mediation of ethanol effects.
    Manzanares J; Ortiz S; Oliva JM; Pérez-Rial S; Palomo T
    Alcohol Alcohol; 2005; 40(1):25-34. PubMed ID: 15550451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectivity profiling of NOP, MOP, DOP and KOP receptor antagonists in the rat spinal nerve ligation model of mononeuropathic pain.
    Rutten K; Schröder W; Christoph T; Koch T; Tzschentke TM
    Eur J Pharmacol; 2018 May; 827():41-48. PubMed ID: 29524385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neurobiology of opioid dependence: implications for treatment.
    Kosten TR; George TP
    Sci Pract Perspect; 2002 Jul; 1(1):13-20. PubMed ID: 18567959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of alcoholism: role of the endogenous opioid system.
    Gianoulakis C; de Waele JP
    Metab Brain Dis; 1994 Jun; 9(2):105-31. PubMed ID: 8072460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous opiates and behavior: 2014.
    Bodnar RJ
    Peptides; 2016 Jan; 75():18-70. PubMed ID: 26551874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: an [11C]diprenorphine PET study.
    Williams TM; Davies SJ; Taylor LG; Daglish MR; Hammers A; Brooks DJ; Nutt DJ; Lingford-Hughes A
    Eur Neuropsychopharmacol; 2009 Oct; 19(10):740-8. PubMed ID: 19595579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Place of the opioid system in biology and treatment of Alcohol Use Disorder].
    Nubukpo P
    Encephale; 2014 Dec; 40(6):457-67. PubMed ID: 25454364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics.
    Ray LA; Chin PF; Miotto K
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):13-22. PubMed ID: 20201811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mosaic of addiction.
    O'Brien CP
    Am J Psychiatry; 2004 Oct; 161(10):1741-2. PubMed ID: 15465965
    [No Abstract]   [Full Text] [Related]  

  • 13. Endogenous opiates and behavior: 2013.
    Bodnar RJ
    Peptides; 2014 Dec; 62():67-136. PubMed ID: 25263178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alcohol dependence and opioid receptor -Pharmacological profile of nalmefene].
    Ohgi Y
    Nihon Yakurigaku Zasshi; 2020; 155(3):145-148. PubMed ID: 32378631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid modulators for alcohol dependence.
    Hillemacher T; Heberlein A; Muschler MA; Bleich S; Frieling H
    Expert Opin Investig Drugs; 2011 Aug; 20(8):1073-86. PubMed ID: 21651459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological gambling: focusing on the addiction, not the activity.
    Tamminga CA; Nestler EJ
    Am J Psychiatry; 2006 Feb; 163(2):180-1. PubMed ID: 16449466
    [No Abstract]   [Full Text] [Related]  

  • 17. Continuous delivery of naltrexone and nalmefene leads to tolerance in reducing alcohol drinking and to supersensitivity of brain opioid receptors.
    Korpi ER; Linden AM; Hytönen HR; Paasikoski N; Vashchinkina E; Dudek M; Herr DR; Hyytiä P
    Addict Biol; 2017 Jul; 22(4):1022-1035. PubMed ID: 26990998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addiction: the clinical interface.
    Nutt D; Lingford-Hughes A
    Br J Pharmacol; 2008 May; 154(2):397-405. PubMed ID: 18414399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addiction and brain reward and antireward pathways.
    Gardner EL
    Adv Psychosom Med; 2011; 30():22-60. PubMed ID: 21508625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid receptor involvement in food deprivation-induced feeding: evaluation of selective antagonist and antisense oligodeoxynucleotide probe effects in mice and rats.
    Hadjimarkou MM; Singh A; Kandov Y; Israel Y; Pan YX; Rossi GC; Pasternak GW; Bodnar RJ
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1188-202. PubMed ID: 15333676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.